Jaguar Animal Health Return on Tangible Equity 2014-2025 | JAGX

Current and historical return on tangible equity values for Jaguar Animal Health (JAGX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Jaguar Animal Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-09-30 $-0.04B $-0.01B 301.89%
2025-06-30 $-0.04B $-0.01B 347.83%
2025-03-31 $-0.04B $-0.02B 410.53%
2024-12-31 $-0.04B $-0.01B 524.14%
2024-09-30 $-0.04B $-0.01B 462.50%
2024-06-30 $-0.04B $0.00B 304.35%
2024-03-31 $-0.04B $-0.01B 257.63%
2023-12-31 $-0.04B $-0.02B 252.31%
2023-09-30 $-0.04B $-0.02B 216.22%
2023-06-30 $-0.05B $-0.02B 246.58%
2023-03-31 $-0.04B $-0.01B 218.18%
2022-12-31 $-0.05B $-0.02B 249.35%
2022-09-30 $-0.05B $-0.02B 337.50%
2022-06-30 $-0.05B $-0.02B 451.06%
2022-03-31 $-0.06B $-0.01B 1221.05%
2021-12-31 $-0.05B $-0.01B -6933.33%
2021-09-30 $-0.05B $0.00B -2800.00%
2021-06-30 $-0.05B $0.01B 2250.00%
2021-03-31 $-0.04B $0.01B 579.31%
2020-12-31 $-0.04B $-0.01B 330.43%
2020-09-30 $-0.04B $-0.02B 318.18%
2020-06-30 $-0.04B $-0.01B 472.73%
2020-03-31 $-0.05B $-0.01B 450.00%
2019-12-31 $-0.05B $-0.01B 391.30%
2019-09-30 $-0.05B $-0.01B 331.03%
2019-06-30 $-0.04B $-0.02B 240.00%
2019-03-31 $-0.03B $-0.02B 209.23%
2018-12-31 $-0.03B $-0.02B 227.59%
2018-09-30 $-0.04B $-0.02B 270.97%
2018-06-30 $-0.03B $-0.02B 185.07%
2018-03-31 $-0.02B $-0.01B 165.52%
2017-12-31 $-0.02B $-0.02B 157.14%
2017-09-30 $-0.01B $-0.02B 64.86%
2017-06-30 $-0.01B $-0.01B 400.00%
2017-03-31 $-0.02B $-0.01B 1066.67%
2016-12-31 $-0.02B $0.00B -1200.00%
2016-09-30 $-0.02B $0.00B -545.45%
2016-06-30 $-0.02B $0.00B -315.79%
2016-03-31 $-0.02B $0.01B -228.57%
2015-12-31 $-0.02B $0.00B -336.84%
2015-09-30 $-0.01B $0.01B -400.00%
2015-06-30 $-0.01B $0.01B -933.33%
2015-03-31 $-0.01B $0.00B 880.00%
2014-12-31 $-0.01B $0.00B 3600.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.012B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $96.263B 33.62
Takeda Pharmaceutical (TAK) Japan $57.594B 11.31
Zoetis (ZTS) United States $56.466B 20.21
BeOne Medicines - (ONC) Switzerland $38.758B 205.48
Daiichi Sankyo, - (DSNKY) Japan $36.201B 18.03
Sandoz Group AG (SDZNY) Switzerland $35.913B 0.00
United Therapeutics (UTHR) United States $20.374B 17.93
Merck (MKKGY) Germany $19.309B 11.90
Shionogi (SGIOY) Japan $19.158B 14.82
Neurocrine Biosciences (NBIX) United States $13.724B 32.93
Ionis Pharmaceuticals (IONS) United States $13.653B 0.00
IPSEN (IPSEY) France $13.565B 0.00
Summit Therapeutics (SMMT) United States $11.760B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) United States $10.875B 0.00
Eisai (ESAIY) $9.041B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.771B 18.59
Crinetics Pharmaceuticals (CRNX) United States $4.864B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.640B 22.03
Stevanato Group S.p.A (STVN) Italy $4.612B 25.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.591B 0.00
Corcept Therapeutics (CORT) United States $4.310B 46.56
Indivior Pharmaceuticals (INDV) United States $4.183B 17.07
NewAmsterdam Pharma (NAMS) Netherlands $3.956B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.166B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.983B 9.52
Hypermarcas (HYPMY) Brazil $2.825B 19.39
Dyne Therapeutics (DYN) United States $2.448B 0.00
Soleno Therapeutics (SLNO) United States $2.175B 0.00
Guardian Pharmacy Services (GRDN) United States $2.140B 41.22
Avadel Pharmaceuticals (AVDL) Ireland $2.112B 0.00
Ocular Therapeutix (OCUL) United States $1.966B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.920B 22.75
Ardelyx (ARDX) United States $1.774B 0.00
Harrow (HROW) United States $1.767B 108.43
Definium Therapeutics (DFTX) United States $1.711B 0.00
Enliven Therapeutics (ELVN) United States $1.658B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.635B 0.00
Oruka Therapeutics (ORKA) United States $1.592B 0.00
Relay Therapeutics (RLAY) United States $1.558B 0.00
Collegium Pharmaceutical (COLL) United States $1.478B 7.32
BioCryst Pharmaceuticals (BCRX) United States $1.380B 81.88
Evotec AG (EVO) Germany $1.279B 0.00
Xeris Biopharma Holdings (XERS) United States $1.198B 0.00
Nektar Therapeutics (NKTR) United States $1.139B 0.00
Savara (SVRA) United States $1.072B 0.00
Cronos Group (CRON) Canada $1.011B 0.00
Theravance Biopharma (TBPH) United States $0.983B 41.28
ARS Pharmaceuticals (SPRY) United States $0.981B 0.00
Aktis Oncology (AKTS) United States $0.902B 0.00
Xencor (XNCR) United States $0.883B 0.00
Esperion Therapeutics (ESPR) United States $0.810B 0.00
KalVista Pharmaceuticals (KALV) United States $0.759B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.747B 17.65
Bioventus (BVS) United States $0.668B 13.68
Rigel Pharmaceuticals (RIGL) United States $0.628B 5.61
ProKidney (PROK) United States $0.605B 0.00
Altimmune (ALT) United States $0.525B 0.00
4D Molecular Therapeutics (FDMT) United States $0.520B 0.00
Lexeo Therapeutics (LXEO) United States $0.514B 0.00
Lyell Immunopharma (LYEL) United States $0.504B 0.00
Organogenesis (ORGO) United States $0.487B 0.00
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Siga Technologies (SIGA) United States $0.479B 6.56
Elite Pharmaceuticals (ELTP) United States $0.474B 0.00
Aquestive Therapeutics (AQST) United States $0.471B 0.00
Nature's Sunshine Products (NATR) United States $0.444B 26.43
Akebia Therapeutics (AKBA) United States $0.401B 0.00
Aclaris Therapeutics (ACRS) United States $0.395B 0.00
USANA Health Sciences (USNA) United States $0.392B 10.93
Protara Therapeutics (TARA) United States $0.333B 0.00
Aldeyra Therapeutics (ALDX) United States $0.330B 0.00
Cybin (HELP) Canada $0.320B 0.00
Relmada Therapeutics (RLMD) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.276B 0.00
Minerva Neurosciences (NERV) United States $0.273B 0.00
Enlivex Therapeutics (ENLV) Israel $0.273B 0.00
Avalo Therapeutics (AVTX) United States $0.270B 0.00
Journey Medical (DERM) United States $0.269B 0.00
OmniAb (OABI) United States $0.249B 0.00
Heron Therapeutics (HRTX) United States $0.233B 0.00
Achieve Life Sciences (ACHV) Canada $0.232B 0.00
Profound Medical (PROF) Canada $0.231B 0.00
MediWound (MDWD) Israel $0.226B 0.00
Context Therapeutics (CNTX) United States $0.217B 0.00
Silence Therapeutics (SLN) United Kingdom $0.212B 0.00
Surrozen (SRZN) United States $0.196B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.194B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
AleAnna (ANNA) United States $0.173B 0.00
Century Therapeutics (IPSC) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.142B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.139B 0.00
Unicycive Therapeutics (UNCY) United States $0.137B 0.00
Prelude Therapeutics (PRLD) United States $0.132B 0.00
Avita Medical (RCEL) United States $0.122B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Incannex Healthcare (IXHL) Australia $0.098B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.096B 0.00
Pyxis Oncology (PYXS) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.085B 36.00
Assertio Holdings (ASRT) United States $0.075B 0.00
PolyPid (PYPD) Israel $0.074B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
Fractyl Health (GUTS) United States $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.25
Dominari Holdings (DOMH) United States $0.056B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Nutriband (NTRB) United States $0.053B 0.00
BioNxt Solutions (BNXTF) Canada $0.051B 0.00
Acrivon Therapeutics (ACRV) United States $0.049B 0.00
Lipocine (LPCN) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Telomir Pharmaceuticals (TELO) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
TherapeuticsMD (TXMD) United States $0.028B 0.00
Wellgistics Health (WGRX) United States $0.027B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
Vyome Holdings (HIND) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Inotiv (NOTV) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
BioVie (BIVI) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Ernexa Therapeutics (ERNA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00